ReportWire

Tag: Addiction treatment

  • After rocky start, hopes up in Oregon drug decriminalization

    After rocky start, hopes up in Oregon drug decriminalization

    [ad_1]

    SALEM, Ore. (AP) — Two years after Oregon residents voted to decriminalize hard drugs and dedicate hundreds of millions of dollars to treatment, few people have requested the services and the state has been slow to channel the funds.

    When voters passed the state’s pioneering Drug Addiction Treatment and Recovery Act in 2020, the emphasis was on treatment as much as on decriminalizing possession of personal-use amounts of heroin, cocaine, methamphetamine and other drugs.

    But Oregon still has among the highest addiction rates in the country. Fatal overdoses have increased almost 20% over the previous year, with over a thousand dead. Over half of addiction treatment programs in the state lack capacity to meet demand because they don’t have enough staffing and funding, according to testimony before lawmakers.

    Supporters want more states to follow Oregon’s lead, saying decriminalization reduces the stigma of addiction and keeps people who use drugs from going to jail and being saddled with criminal records. How Oregon is faring will almost certainly be taken into account if another state considers decriminalizing.

    Steve Allen, behavioral health director of the Oregon Health Authority, acknowledged the rocky start, even as he announced a “true milestone” has been reached, with more than $302 million being sent to facilities to help people get off drugs, or at least use them more safely.

    “The road to get here has not been easy. Oregon is the first state to try such a bold and transformative approach,” Allen told a state Senate committee Wednesday.

    One expert, though, told the lawmakers the effort is doomed unless people with addictions are nudged into treatment.

    “If there is no formal or informal pressure on addicted people to seek treatment and recovery and thereby stop using drugs, we should expect continuing high rates of drug use, addiction and attendant harm,” said Keith Humphreys, an addiction researcher and professor at Stanford University and former senior adviser in the White House Office of National Drug Control Policy.

    Of 16,000 people who accessed services in the first year of decriminalization, only 0.85% entered treatment, the health authority said. A total of 60% received “harm reduction” like syringe exchanges and overdose medications. An additional 15% got help with housing needs, and 12% obtained peer support.

    The Drug Addiction Treatment and Recovery Act, also known as Measure 110, has become a campaign issue this year as Republicans seek to wrest the governorship from Democrats, who have held it since 1987.

    “I voted no on Measure 110 because decriminalizing hard drugs like heroin and meth was and is a terrible idea,” said GOP candidate Christine Drazan, who supports asking voters to repeal it. “As expected, it has made our addiction crisis worse, not better.”

    Unaffiliated candidate Betsy Johnson, a former veteran lawmaker, said she would work to repeal what she called a “failed experiment.”

    A spokeswoman for Democratic candidate Tina Kotek, a former House speaker, said Drazan and Johnson “want to go against the will of the voters. … Oregonians do not want to go backward.”

    “As governor, Tina will make sure that the state is delivering on what voters demanded: expanded recovery services statewide,” spokeswoman Katie Wertheimer said.

    Under the law, people receive a citation, with the maximum $100 fine waived if they call a hotline for a health assessment. But most of the more than 3,100 tickets issued so far have been ignored, Oregon Public Broadcasting reported. Few people have dialed the hotline.

    Tera Hurst, executive director of Oregon Health Justice Recovery Alliance, which is focused on implementing Measure 110, said coerced treatment is ineffective. Hurst said it’s important to focus on “just building a system of care to make sure that people who need access can get access.”

    Allen called the outlay of million of dollars — which come from taxes on Oregon’s legal marijuana industry — a “pivotal moment.”

    “Measure 110 is launching and will provide critical supports and services for people, families and communities,” he told the Senate committee.

    It will take time, though, to use the funds to build out the services.

    Centro Latino Americano, a nonprofit serving Latino immigrant families, plans to use its $4.5 million share to move treatment services to a bigger space and hire more staff, said manager Basilio Sandoval.

    “Measure 110 makes it possible for us to provide this service free of charge,” Sandoval said. “This allows us to reach people we could not serve previously because of a lack of insurance.”

    Scott Winkels, lobbyist for the League of Oregon Cities, said residents are running out of patience.

    ”People are going to need to see progress,” Winkels said. “If you’re living in a community where you’re finding needles, how many times do you need to see a needle in a park before you lose your cool?”

    [ad_2]

    Source link

  • Cordant Offers Virtual Drug Testing to Provide Drug Courts and Other Government Agencies the Ability to Maintain Accountability for Participants During COVID-19

    Cordant Offers Virtual Drug Testing to Provide Drug Courts and Other Government Agencies the Ability to Maintain Accountability for Participants During COVID-19

    [ad_1]

    Press Release



    updated: Jun 30, 2020

    ​​​​​​​Cordant Health Solutions® (Cordant) offers a video-observed oral fluid drug testing solution ideal for helping drug courts and other government agencies continue to monitor participants’ adherence to their treatment programs during safer at home orders. Saliva testing is a useful tool that has been recognized as an effective method for testing in addiction treatment settings according to the American Society of Addiction Medicine.

    Due to the need for social distancing to minimize exposure to COVID-19, many government agencies are struggling to maintain their monitoring programs. While some may already offer virtual services, drug testing to monitor adherence is a challenge in this environment.

    After courts began suspending cases due to safety concerns, officials at the Hamilton County Adult Probation Department in Indiana realized that participants who were in treatment programs for substance use disorder were at risk of relapse or even overdose without drug monitoring.

    “At first, we thought delaying testing for a week or 10 days would be okay,” said Madonna Wagoner, director of the department. “But once it became close to a month, we knew we needed to figure out a better plan to help our clients stay compliant.”

    As drug testing frequency decreased, participants in the drug court program, who are at higher risk of relapse, began expressing their discomfort with the lack of screening.

    “Our clients were telling us they want more screening, that they rely on it to stay adherent to their drug treatment program,” said Krista Radican, assistant director adult probation/drug court coordinator. “Several participants self-reported relapses, and some worried aloud to their probation officers or counselors early on that they didn’t know how they would get through the pandemic sober.”

    Radican also went on to say that they looked to national resources such as the National Association of Drug Court Professionals (NADCP) for best practices, but “there are no best practices for the situation we’re in right now. Nobody was prepared for a crisis like this.”

    Cordant’s video-observed saliva testing is one solution they have adopted to help participants. Video saliva drug testing is easily observed and can be done conveniently in the participant’s home, reducing their risk of exposure to COVID-19. The entire process is conducted under video supervision by a remote Cordant collection specialist or a probation officer.  

    “Any disruption in addiction treatment, combined with the increased stress and uncertainty caused by the current pandemic, can increase the chance of relapse in this vulnerable population,” said Sue Sommer, CEO and president of Cordant. “By having a solution like video-observed saliva drug testing available, many of our clients, like Hamilton County, were able to adjust their operations to be done remotely, minimizing the effect in disruption of care for participants.”

    Agencies interested in learning more about Cordant’s solutions can contact Cordant at sales@cordanths.com or 844-848-5955.

    About Cordant Health Solutions®

    ​Cordant is committed to developing solutions for payers, clinicians and organizations involved with substance use disorder, pain management and criminal justice agencies. Cordant is one of the only healthcare companies that offers monitoring and risk assessment tools through its innovative drug testing options and full-service, high-touch pharmacies, which specialize in the complex management and dispensing of controlled substances. Cordant’s testing protocols and digital case-management tools help clients become more efficient and effective in using drug testing programs to monitor patient adherence, reduce risk and improve patient outcomes.

    Media Contact:
    ​Tiffany Tuetken
    ​303-570-4585
    ​ttuetken@cordanths.com

    Source: Cordant Health Solutions

    [ad_2]

    Source link